Private investment firm Sarissa Capital Management of Greenwich, Conn., has taken a 6.2 percent stake in Cambridge-based Ariad Pharmaceuticals Inc. and plans to seek representation on the drug maker's board, according to a regulatory filing Tuesday.
http://www.boston.com/business/technology/2013/10/29/connecticut-investment-firm-takes-stake-ariad/whviBP3mmCCkfLkU8r9FwI/story.html
http://www.boston.com/business/technology/2013/10/29/connecticut-investment-firm-takes-stake-ariad/whviBP3mmCCkfLkU8r9FwI/story.html
No comments:
Post a Comment